CIPLA expands its African footprint with Ghana launch

As part of its "Africa for Africa" strategy, and in line with ensuring equitable access to quality medication across the continent, pharmaceutical company Cipla is expanding its footprint into Ghana.

CEO of Cipla Africa, Paul Miller, said: “We envision a future where everyone in Ghana has equitable access to quality, life-saving medicine, and innovative therapies.

“In line with the United Nations Sustainable Development Goals, we are focused on improving health and promoting well-being. Addressing disparities by enabling access to medication is one of the most important things we can do in any country to help improve health outcomes. Because, we believe that healthy people are the foundation of healthy economies.”

“We want to unlock our continent’s well-being potential and drive inclusive economic growth.

“As a global pharmaceutical company, we’re focused on agile and sustainable growth and complex generics and increasing our portfolio in emerging markets. Thanks to our philosophy of ‘Caring for life’, we are trusted by healthcare professionals and patients across the world,” said Miller.

Initially, Cipla’s therapeutic portfolio in the Ghanaian market will focus on respiratory, gastro, cardiovascular/ diabetes management, pain/colds/flu and anti-infectives. The plan is to work closely with local healthcare professionals and focus on patient education in Ghana to ensure better health outcomes.

Investment in Africa is crucial for catalysing job creation, infrastructure development and sustainable economic prosperity. Empowering local communities also contributes to the socio-economic advancement of the country.

Cipla is intent on making a difference beyond the pill by investing in corporate social responsibility projects to upliftment local communities and is will also focus sustainability or environmental initiatives.

Miller said: “Our philosophy is to do well while doing good. We will explore opportunities in Ghana to make a positive impact. As an example, our first corporate social investment in Ghana is through our Miles for Smiles initiative (in partnership with Operation Smile) to help fund corrective surgeries for people born with cleft conditions.

“We are excited to invest in Ghana to make a sustainable, long-term impact,” concluded Miller.